Antigen News and Research

RSS

Study provides insights into genetics underlying debilitating pediatric kidney disease

New research provides insights into the genetics underlying a debilitating kidney disease in children. The findings, which appear in an upcoming issue of the Journal of the American Society of Nephrology, could lead to new diagnostics and, ultimately, treatments.

14 Jun 2018

Cureworks collaborative aims to accelerate development of immunotherapies for pediatric cancer

Seattle Children's, with participating members Children's National Health System, BC Children's Hospital and Children's Hospital Los Angeles, has launched CureWorks, an international collaborative of leading academic children's hospitals determined to accelerate the development of immunotherapy treatments for childhood cancer.

12 Jun 2018

Research identifies new genetic variations that could indicate higher prostate cancer risk

As the result of a six-year long research process, Fredrick R. Schumacher, PhD, a cancer epidemiology researcher at Case Western Reserve University School of Medicine, and an international team of more than 100 colleagues have identified 63 new genetic variations that could indicate higher risk of prostate cancer in men of European descent.

12 Jun 2018

Customising T-cells for cancer immunotherapy

T-cell immunotherapy is revolutionizing cancer treatments. CD8+ T cells are modified to recognize tumor-specific antigens and induce an immune response.

12 Jun 2018

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Researchers from GeoVax have developed a flexible "Plug and Play" technology platform that delivers single-dose vaccines that fully protect against emerging infectious diseases such as Zika, Lassa fever, and Ebola.

11 Jun 2018

More frequent post treatment monitoring does not improve survival in prostate cancer patients, finds study

African-American men with prostate cancer show stronger response to hormone therapy

African-American men with advanced prostate cancer might be more responsive than white men to an anti-androgen drug and steroids, according to a study led by Duke Cancer Institute researchers.

4 Jun 2018

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

The University of Texas MD Anderson Cancer Center and Amgen today announced two multi-year collaboration agreements aimed at accelerating development of a variety of Amgen's early-stage oncology therapies for patients with leukemia, myelodysplastic syndromes, multiple myeloma, small-cell lung cancer, and other non-lung cancers with small-cell histologies.

1 Jun 2018

Discovering Antibodies with Universal Specificity

Professor Hedda Wardemann discusses our current knowledge of antibody specificity and how her research team are challenging this, through the discovery of anti-bacterial antibodies with universal specificity.

1 Jun 2018

Research sheds light on genetic characteristics of Indonesia's rotavirus

Rotavirus A causes acute diarrhea in young children, and infects both animals and humans worldwide. A Japanese research group has found that the acute gastroenteritis infecting children in Indonesia between 2015 and 2016 was caused by dominant strains of equine-like G3 rotavirus, genetically different from human strains of the virus.

31 May 2018

Study finds no link between surveillance intensity and detection of recurrence or survival in CRC patients

A national retrospective study led by researchers at The University of Texas MD Anderson Cancer Center found no association between intensity of post-treatment surveillance and detection of recurrence or overall survival in patients with stage I, II or III colorectal cancer.

23 May 2018

Determining the Optimal Biomarker Frequency for Biosensors

Chi-En Lin won Metrohm’s Young Chemist of the Year award for research into optimal biomarker frequencies and how it can be applied.

From Metrohm USA Inc. 22 May 2018

New study shows declines in prostate cancer screening, diagnoses and treatment

A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well as decreases in the use of definitive treatments in men who have been diagnosed.

21 May 2018

New blood test could help avoid more than 40% of prostate biopsies, study finds

A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.

18 May 2018

Antigen News and Research

Study provides insights into genetics underlying debilitating pediatric kidney disease

Cureworks collaborative aims to accelerate development of immunotherapies for pediatric cancer

Research identifies new genetic variations that could indicate higher prostate cancer risk

Customising T-cells for cancer immunotherapy

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

More frequent post treatment monitoring does not improve survival in prostate cancer patients, finds study

African-American men with prostate cancer show stronger response to hormone therapy

MD Anderson and Amgen collaborate to accelerate early-stage oncology therapies

Discovering Antibodies with Universal Specificity

Research sheds light on genetic characteristics of Indonesia's rotavirus

Study finds no link between surveillance intensity and detection of recurrence or survival in CRC patients

Determining the Optimal Biomarker Frequency for Biosensors

New study shows declines in prostate cancer screening, diagnoses and treatment

New blood test could help avoid more than 40% of prostate biopsies, study finds

Whole genome sequencing could prevent transfusion reactions

Study finds body temperature as major barrier to potential dengue, Zika vaccine

VA health care study: Many prostate cancer patients choose active surveillance over immediate therapy

Prenatal test to determine child's rhesus factor found to be reliable, but benefit is unclear

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

Immune system can produce 'universal antibodies' against various microorganisms

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics